Micro Pollutant,MP Category,Initial Concentration of MP (mg/L),Compound MW (g/mol),Compound Charge,Log D (pH=6.5-7),Log Kow,pKa,Stokes Radius/Compound size ,Initial FS pH,Type of MB,FO membrane description,MB Contact Angle (°),MB Zeta Potential,Draw Solution,DS MW (g mol-1),DS Concentration (M),Operating Time (h),Cross Flow Velocity (cm/s),"Water Flux, Jw (LMH)","Reverse Salt Flux, Js (gMH)",Temperature (⁰C),Removal Rate (%),Reference,Reference ID,Additional references,ID number,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.09,0.33,9.6,0.39,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,1,10,8.5,7.7,0.08,20,79.8,"(Kim, 2019)",1,,1,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,216,0,2.64,2.2,2.27,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,1,10,8.5,7.7,0.08,20,76.9,"(Kim, 2019)",1,,2,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,1.00E-02,218,0,0.83,0.91,12.26,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,1,10,8.5,7.7,0.08,20,89.9,"(Kim, 2019)",1,,3,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194,0,-0.63,-0.07,0.52,0.33,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,1,10,8.5,7.7,0.08,20,81.3,"(Kim, 2019)",1,,4,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.09,0.33,9.6,0.39,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,2,10,8.5,9.5,0.08,20,79.8,"(Kim, 2019)",1,,5,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,216,0,2.64,2.2,2.27,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,2,10,8.5,9.5,0.08,20,83.2,"(Kim, 2019)",1,,6,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,1.00E-02,218,0,0.83,0.91,12.26,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,2,10,8.5,9.5,0.08,20,92.4,"(Kim, 2019)",1,,7,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194,0,-0.63,-0.07,0.52,0.33,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Monoammonium Phosphate,115,2,10,8.5,9.5,0.08,20,87.2,"(Kim, 2019)",1,,8,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.09,0.33,9.6,0.39,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,1,10,8.5,7.6,0.49,20,88.7,"(Kim, 2019)",1,,9,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,216,0,2.64,2.2,2.27,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,1,10,8.5,7.6,0.49,20,92,"(Kim, 2019)",1,,10,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,1.00E-02,218,0,0.83,0.91,12.26,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,1,10,8.5,7.6,0.49,20,91.6,"(Kim, 2019)",1,,11,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194,0,-0.63,-0.07,0.52,0.33,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,1,10,8.5,7.6,0.49,20,84.4,"(Kim, 2019)",1,,12,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.09,0.33,9.6,0.39,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,2,10,8.5,9.2,0.59,20,94.2,"(Kim, 2019)",1,,13,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,216,0,2.64,2.2,2.27,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,2,10,8.5,9.2,0.59,20,88.3,"(Kim, 2019)",1,,14,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,1.00E-02,218,0,0.83,0.91,12.26,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,2,10,8.5,9.2,0.59,20,92,"(Kim, 2019)",1,,15,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194,0,-0.63,-0.07,0.52,0.33,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,Diammonium Phosphate,132.1,2,10,8.5,9.2,0.59,20,86.7,"(Kim, 2019)",1,,16,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.09,0.33,9.6,0.39,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,1,10,8.5,11.7,0.51,20,97.3,"(Kim, 2019)",1,,17,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,216,0,2.64,2.2,2.27,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,1,10,8.5,11.7,0.51,20,88.4,"(Kim, 2019)",1,,18,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,1.00E-02,218,0,0.83,0.91,12.26,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,1,10,8.5,11.7,0.51,20,94.7,"(Kim, 2019)",1,,19,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194,0,-0.63,-0.07,0.52,0.33,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,1,10,8.5,11.7,0.51,20,85.5,"(Kim, 2019)",1,,20,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.09,0.33,9.6,0.39,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,2,10,8.5,17.1,0.86,20,97.6,"(Kim, 2019)",1,,21,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,216,0,2.64,2.2,2.27,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,2,10,8.5,17.1,0.86,20,91.5,"(Kim, 2019)",1,,22,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,1.00E-02,218,0,0.83,0.91,12.26,0.35,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,2,10,8.5,17.1,0.86,20,95,"(Kim, 2019)",1,,23,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194,0,-0.63,-0.07,0.52,0.33,7.05,HTI CTA FO,Fertilizer-drawn forward osmosis (FDFO) membrane process (active layer facing FS),79.5,-6.87,KCl,74.6,2,10,8.5,17.1,0.86,20,87.2,"(Kim, 2019)",1,,24,,,,,,,,,,,,,,,,,,
"1,4-Dioxane",Cosmetic Toxin,9.00E-03,88,0,-0.17,-0.27,-3.9,0.26,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,55.6,(Linares et al. 2011),3,file:///C:/Users/ct619/Downloads/Desalination_of_Red_Sea_water_using_both_electrodi.pdf,25,,,,,,,,,,,,,,,,,,
Paracetamol,Pharmaceutical,1.07E-03,151,0,0.23,0.46,9.38,0.54,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,48.6,(Linares et al. 2011),3,https://www.lenntech.com/calculators/osmotic/osmotic-pressure.htm,26,,,,,,,,,,,,,,,,,,
Metronidazole,Pharmaceutical,8.70E-03,171,0,-0.27,-0.14,14.44,0.53,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,65.5,(Linares et al. 2011),3,https://www.researchgate.net/publication/275251989_Desalination_of_Red_Sea_water_using_both_electrodialysis_and_reverse_osmosis_as_complementary_methods,27,,,,,,,,,,,,,,,,,,
Phenazone,Nonsteroidal anti-inflammatory,1.18E-03,188,0,0.54,0.44,0.65,0.55,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,84.7,(Linares et al. 2011),3,,28,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,9.60E-03,194,0,-0.45,-0.07,0.52,0.39,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,80.2,(Linares et al. 2011),3,,29,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,8.50E-03,228,0,3.86,3.32,10.29,0.56,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,40,(Linares et al. 2011),3,,30,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.00E-03,236,0,2.58,2.45,13.9,0.6,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,67,(Linares et al. 2011),3,,31,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,6.40E-03,296,0,3.98,3.9,10.33,0.54,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,87.5,(Linares et al. 2011),3,,32,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,7.00E-04,206,-1,3.97,3.5,4.41,0.56,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,92.9,(Linares et al. 2011),3,,33,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,1.04E-03,230,-1,0.34,2.88,4.84,0.58,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,96.5,(Linares et al. 2011),3,,34,,,,,,,,,,,,,,,,,,
Fenoprofen,Pharmaceutical,1.09E-03,242,0,0.38,3.72,4.2,0.56,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,93.5,(Linares et al. 2011),3,,35,,,,,,,,,,,,,,,,,,
Gemfibrozil,Pharmaceutical,1.13E-03,250,0,2.3,4.3,4.75,0.6,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,95.6,(Linares et al. 2011),3,,36,,,,,,,,,,,,,,,,,,
Ketoprofen,Pharmaceutical,9.20E-03,254,0,-0.13,2.91,4.23,0.56,7.2,HTI PMMA FO,Poly(methyl methacrylate) (PMMA) Flat-sheet membrane,58.8,-22.8,NaCl,430.18,0.65,48,,4,,20,96.5,(Linares et al. 2011),3,,37,,,,,,,,,,,,,,,,,,
Phenol,Organic Compounds,4.71E-01,94.11,0,1.54,1.67,10.2,0.44,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane (active layer facing FS),62,-6,NaCl,58.44,1,96,9.8,8.8,4,21,20.68,(Heo et al. 2013),4,,38,,,,,,,,,,,,,,,,,,
4-Chlorophenol,Detergent,6.43E-01,128.6,0,2.42,2.27,8.96,0.55,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,9.8,8.8,4,21,28.2,(Heo et al. 2013),4,,39,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.08E+00,215.7,0,2.64,2.2,3.2,0.35,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,9.8,8.8,4,21,34,(Heo et al. 2013),4,,40,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.18E+00,236.3,0,1.89,2.77,13.94,0.37,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,9.8,8.8,4,21,68.01,(Heo et al. 2013),4,,41,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,1.27E+00,253.3,-1,-0.22,0.79,1.39,0.43,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,9.8,8.8,4,21,66.4,(Heo et al. 2013),4,,42,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,1.48E+00,296.4,0,3.98,3.9,10.33,0.55,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,9.8,8.8,4,21,,(Heo et al. 2013),4,,43,,,,,,,,,,,,,,,,,,
Phenol,Organic Compounds,4.71E-01,94.11,0,1.54,1.67,10.2,0.44,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane (active layer facing FS),62,-6,NaCl,58.44,1,96,58.8,7.5,3,21,22,(Heo et al. 2013),4,,44,,,,,,,,,,,,,,,,,,
4-Chlorophenol,Detergent,6.43E-01,128.6,0,2.42,2.27,8.96,0.45,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,58.8,7.5,3,21,38.3,(Heo et al. 2013),4,,45,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.08E+00,215.7,0,2.64,2.2,3.2,0.35,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,58.8,7.5,3,21,48.5,(Heo et al. 2013),4,,46,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.18E+00,236.3,0,1.89,2.77,13.94,0.37,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,58.8,7.5,3,21,82.5,(Heo et al. 2013),4,,47,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,1.27E+00,253.3,-1,-0.22,0.79,1.39,0.43,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,58.8,7.5,3,21,89.6,(Heo et al. 2013),4,,48,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,1.48E+00,296.4,0,3.98,3.9,10.33,0.55,7,HTI CTA FO,Cellulose triacetate-based flat-shee FO membrane,62,-6,NaCl,58.44,1,96,58.8,7.5,3,21,NaN,(Heo et al. 2013),4,,49,,,,,,,,,,,,,,,,,,
Salicylic Acid,Personal care product,7.50E-04,138.12,-1,-1.13,2.26,3.01,0.53,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,46.8,(Alturki et al. 2013),5,,50,,,,,,,,,,,,,,,,,,
Paracetamol,Pharmaceutical,7.50E-04,151.16,0,0.47,0.47,9.86,0.36,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,29.9,(Alturki et al. 2013),5,,51,,,,,,,,,,,,,,,,,,
Propylparaben,Pharmaceutical,7.50E-04,180.2,0,2.88,2.9,8.23,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,44.9,(Alturki et al. 2013),5,,52,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,7.50E-04,194.19,0,-0.63,-0.63,0.52,0.34,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,79.1,(Alturki et al. 2013),5,,53,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,7.50E-04,206.28,-1,0.94,3.5,4.41,0.44,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,75,(Alturki et al. 2013),5,,54,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,7.50E-04,218.25,0,0.83,0.83,12.26,0.46,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,94.6,(Alturki et al. 2013),5,,55,,,,,,,,,,,,,,,,,,
Meprobamate,Pharmaceutical,7.50E-04,218.25,0,-1.34,0.7,13.09,0.41,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,92.2,(Alturki et al. 2013),5,,56,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,7.50E-04,230.26,-1,0.34,2.88,4.84,0.43,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,77.8,(Alturki et al. 2013),5,,57,,,,,,,,,,,,,,,,,,
Gemfibrozil,Pharmaceutical,7.50E-04,250.33,-1,2.3,4.3,4.75,0.48,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,71,(Alturki et al. 2013),5,,58,,,,,,,,,,,,,,,,,,
Dilantin,Pharmaceutical,7.50E-04,252.27,0,1.42,1.42,8.28,0.55,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,94.5,(Alturki et al. 2013),5,,59,,,,,,,,,,,,,,,,,,
Triamterene,Pharmaceutical,7.50E-04,253.26,-1,1.03,1.16,6.28,0.49,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,92.6,(Alturki et al. 2013),5,,60,,,,,,,,,,,,,,,,,,
Ketoprofen,Pharmaceutical,7.50E-04,254.28,-1,0.19,2.91,4.23,0.46,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,89,(Alturki et al. 2013),5,,61,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,7.50E-04,266.34,1,-2.67,0.33,9.43,0.41,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98.8,(Alturki et al. 2013),5,,62,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,7.50E-04,277.4,1,1.57,4.41,9.18,0.51,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,99,(Alturki et al. 2013),5,,63,,,,,,,,,,,,,,,,,,
Triclosan,Detergent,7.50E-04,289.54,0,4.93,5.17,7.8,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,89,(Alturki et al. 2013),5,,64,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,7.50E-04,290.32,1,0.26,0.59,7.04,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98.8,(Alturki et al. 2013),5,,65,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,7.50E-04,296.25,-1,1.77,4.55,4.18,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,90.2,(Alturki et al. 2013),5,,66,,,,,,,,,,,,,,,,,,
Fluoxetine,Pharmaceutical,7.50E-04,309.33,1,1.15,3.93,10.05,0.53,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,97,(Alturki et al. 2013),5,,67,,,,,,,,,,,,,,,,,,
Triclocarban,Herbicide,7.50E-04,315.58,0,6.07,6.07,12.77,0.5,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98,(Alturki et al. 2013),5,,68,,,,,,,,,,,,,,,,,,
Clozapine,Pharmaceutical,7.50E-04,326.82,1,2.17,3.94,7.33,0.61,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,97.5,(Alturki et al. 2013),5,,69,,,,,,,,,,,,,,,,,,
Omeprazole,Pharmaceutical,7.50E-04,345.42,0,2.35,2.36,8.78,0.57,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,96.4,(Alturki et al. 2013),5,,70,,,,,,,,,,,,,,,,,,
Hydroxyzine,Pharmaceutical,7.50E-04,374.9,1,2.15,2.32,14.41,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,97,(Alturki et al. 2013),5,,71,,,,,,,,,,,,,,,,,,
Risperidone,Pharmaceutical,7.50E-04,410.48,0,1.53,2.68,8.07,0.58,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,99.4,(Alturki et al. 2013),5,,72,,,,,,,,,,,,,,,,,,
Simvastatin,Pharmaceutical,7.50E-04,418.57,0,4.72,4.72,13.49,0.57,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98.8,(Alturki et al. 2013),5,,73,,,,,,,,,,,,,,,,,,
Simvastatin hydroxy acid,Pharmaceutical,7.50E-04,436.58,-1,1.79,4.53,4.31,0.5,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98.8,(Alturki et al. 2013),5,,74,,,,,,,,,,,,,,,,,,
Verapamil,Pharmaceutical,7.50E-04,454.6,0,2.5,4.02,8.97,0.54,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,99.4,(Alturki et al. 2013),5,,75,,,,,,,,,,,,,,,,,,
DEET,Pesticide,7.50E-04,191.27,0,2.42,2.42,-1.37,0.33,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,68.1,(Alturki et al. 2013),5,,76,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,7.50E-04,215.68,0,2.64,2.64,2.27,0.4,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,64.8,(Alturki et al. 2013),5,,77,,,,,,,,,,,,,,,,,,
Linuron,Pesticide,7.50E-04,249.09,0,3.12,3.12,12.13,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,56,(Alturki et al. 2013),5,,78,,,,,,,,,,,,,,,,,,
4-tert-Octylphenol,Detergent,7.50E-04,206.32,0,5.18,5.18,10.15,0.37,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,78.5,(Alturki et al. 2013),5,,79,,,,,,,,,,,,,,,,,,
4-Nonylphenol,Endocrine disrupting chemicals,7.50E-04,220.35,0,6.14,6.14,10.15,0.41,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98.2,(Alturki et al. 2013),5,,80,,,,,,,,,,,,,,,,,,
Estrone,Hormones,7.50E-04,270.37,0,3.62,3.62,10.25,0.34,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,94,(Alturki et al. 2013),5,,81,,,,,,,,,,,,,,,,,,
17beta-estradiol,Hormones,7.50E-04,272.38,0,4.15,4.14,10.27,0.33,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,96,(Alturki et al. 2013),5,,82,,,,,,,,,,,,,,,,,,
17alpha-Estradiol,Hormones,7.50E-04,272.38,0,4.15,4.14,10.27,0.33,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,95,(Alturki et al. 2013),5,,83,,,,,,,,,,,,,,,,,,
Androstenedione,Hormones,7.50E-04,286.41,0,2.72,2.72,,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,94,(Alturki et al. 2013),5,,84,,,,,,,,,,,,,,,,,,
Estriol,Hormones,7.50E-04,288.38,0,2.53,2.53,10.25,0.32,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,87,(Alturki et al. 2013),5,,85,,,,,,,,,,,,,,,,,,
Testosterone,Hormones,7.50E-04,288.42,0,3.18,3.18,15.06,0.44,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,92,(Alturki et al. 2013),5,,86,,,,,,,,,,,,,,,,,,
Etiocholanolone,Hormones,7.50E-04,290.44,0,3.93,3.93,15.14,0.42,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,98,(Alturki et al. 2013),5,,87,,,,,,,,,,,,,,,,,,
Androsterone,Hormones,7.50E-04,290.44,0,3.93,3.93,15.14,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,97,(Alturki et al. 2013),5,,88,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,7.50E-04,296.4,0,3.98,4.11,10.24,0.31,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,2,25,9,11.01,8.5,22.5,99,(Alturki et al. 2013),5,,89,,,,,,,,,,,,,,,,,,
Salicylic Acid,Personal care product,7.50E-04,138.12,-1,-1.13,2.26,3.01,0.53,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,5.55,(Alturki et al. 2013),5,,90,,,,,,,,,,,,,,,,,,
Paracetamol,Pharmaceutical,7.50E-04,151.16,0,0.47,0.47,9.86,0.36,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,18,(Alturki et al. 2013),5,,91,,,,,,,,,,,,,,,,,,
Propylparaben,Pharmaceutical,7.50E-04,180.2,0,2.88,2.9,8.23,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,65,(Alturki et al. 2013),5,,92,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,7.50E-04,194.19,0,-0.63,-0.63,0.52,0.34,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,67,(Alturki et al. 2013),5,,93,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,7.50E-04,206.28,-1,0.94,3.5,4.41,0.44,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,79.5,(Alturki et al. 2013),5,,94,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,7.50E-04,218.25,0,0.83,0.83,12.26,0.46,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,84,(Alturki et al. 2013),5,,95,,,,,,,,,,,,,,,,,,
Meprobamate,Pharmaceutical,7.50E-04,218.25,0,-1.34,0.7,13.09,0.41,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,87,(Alturki et al. 2013),5,,96,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,7.50E-04,230.26,-1,0.34,2.88,4.84,0.43,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,83.2,(Alturki et al. 2013),5,,97,,,,,,,,,,,,,,,,,,
Gemfibrozil,Pharmaceutical,7.50E-04,250.33,-1,2.3,4.3,4.75,0.48,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,70.3,(Alturki et al. 2013),5,,98,,,,,,,,,,,,,,,,,,
Dilantin,Pharmaceutical,7.50E-04,252.27,0,1.42,1.42,8.28,0.55,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,86.6,(Alturki et al. 2013),5,,99,,,,,,,,,,,,,,,,,,
Triamterene,Pharmaceutical,7.50E-04,253.26,-1,1.03,1.16,6.28,0.49,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,86,(Alturki et al. 2013),5,,100,,,,,,,,,,,,,,,,,,
Ketoprofen,Pharmaceutical,7.50E-04,254.28,-1,0.19,2.91,4.23,0.46,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,90.3,(Alturki et al. 2013),5,,101,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,7.50E-04,266.34,1,-2.67,0.33,9.43,0.41,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,97.3,(Alturki et al. 2013),5,,102,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,7.50E-04,277.4,1,1.57,4.41,9.18,0.51,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,96,(Alturki et al. 2013),5,,103,,,,,,,,,,,,,,,,,,
Triclosan,Detergent,7.50E-04,289.54,0,4.93,5.17,7.8,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,91.7,(Alturki et al. 2013),5,,104,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,7.50E-04,290.32,1,0.26,0.59,7.04,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,94.6,(Alturki et al. 2013),5,,105,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,7.50E-04,296.25,-1,1.77,4.55,4.18,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,87.6,(Alturki et al. 2013),5,,106,,,,,,,,,,,,,,,,,,
Fluoxetine,Pharmaceutical,7.50E-04,309.33,1,1.15,3.93,10.05,0.53,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,95.7,(Alturki et al. 2013),5,,107,,,,,,,,,,,,,,,,,,
Triclocarban,Herbicide,7.50E-04,315.58,0,6.07,6.07,12.77,0.5,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,98,(Alturki et al. 2013),5,,108,,,,,,,,,,,,,,,,,,
Clozapine,Pharmaceutical,7.50E-04,326.82,1,2.17,3.94,7.33,0.61,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,96.2,(Alturki et al. 2013),5,,109,,,,,,,,,,,,,,,,,,
Omeprazole,Pharmaceutical,7.50E-04,345.42,0,2.35,2.36,8.78,0.57,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,96.3,(Alturki et al. 2013),5,,110,,,,,,,,,,,,,,,,,,
Hydroxyzine,Pharmaceutical,7.50E-04,374.9,1,2.15,2.32,14.41,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,97.8,(Alturki et al. 2013),5,,111,,,,,,,,,,,,,,,,,,
Risperidone,Pharmaceutical,7.50E-04,410.48,0,1.53,2.68,8.07,0.58,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,98.6,(Alturki et al. 2013),5,,112,,,,,,,,,,,,,,,,,,
Simvastatin,Pharmaceutical,7.50E-04,418.57,0,4.72,4.72,13.49,0.57,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,98.6,(Alturki et al. 2013),5,,113,,,,,,,,,,,,,,,,,,
Simvastatin hydroxy acid,Pharmaceutical,7.50E-04,436.58,-1,1.79,4.53,4.31,0.5,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,99.5,(Alturki et al. 2013),5,,114,,,,,,,,,,,,,,,,,,
Verapamil,Pharmaceutical,7.50E-04,454.6,0,2.5,4.02,8.97,0.54,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,98.6,(Alturki et al. 2013),5,,115,,,,,,,,,,,,,,,,,,
DEET,Pesticide,7.50E-04,191.27,0,2.42,2.42,-1.37,0.33,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,57,(Alturki et al. 2013),5,,116,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,7.50E-04,215.68,0,2.64,2.64,2.27,0.4,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,49,(Alturki et al. 2013),5,,117,,,,,,,,,,,,,,,,,,
Linuron,Pesticide,7.50E-04,249.09,0,3.12,3.12,12.13,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,27,(Alturki et al. 2013),5,,118,,,,,,,,,,,,,,,,,,
4-tert-Octylphenol,Detergent,7.50E-04,206.32,0,5.18,5.18,10.15,0.37,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,30,(Alturki et al. 2013),5,,119,,,,,,,,,,,,,,,,,,
4-Nonylphenol,Endocrine disrupting chemicals,7.50E-04,220.35,0,6.14,6.14,10.15,0.41,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,97,(Alturki et al. 2013),5,,120,,,,,,,,,,,,,,,,,,
Estrone,Hormones,7.50E-04,270.37,0,3.62,3.62,10.25,0.34,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,80,(Alturki et al. 2013),5,,121,,,,,,,,,,,,,,,,,,
17beta-estradiol,Hormones,7.50E-04,272.38,0,4.15,4.14,10.27,0.33,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,80,(Alturki et al. 2013),5,,122,,,,,,,,,,,,,,,,,,
17alpha-Estradiol,Hormones,7.50E-04,272.38,0,4.15,4.14,10.27,0.33,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,81,(Alturki et al. 2013),5,,123,,,,,,,,,,,,,,,,,,
Androstenedione,Hormones,7.50E-04,286.41,0,2.72,2.72,,0.39,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,90,(Alturki et al. 2013),5,,124,,,,,,,,,,,,,,,,,,
Estriol,Hormones,7.50E-04,288.38,0,2.53,2.53,10.25,0.32,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,86,(Alturki et al. 2013),5,,125,,,,,,,,,,,,,,,,,,
Testosterone,Hormones,7.50E-04,288.42,0,3.18,3.18,15.06,0.44,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,89,(Alturki et al. 2013),5,,126,,,,,,,,,,,,,,,,,,
Etiocholanolone,Hormones,7.50E-04,290.44,0,3.93,3.93,15.14,0.42,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,93,(Alturki et al. 2013),5,,127,,,,,,,,,,,,,,,,,,
Androsterone,Hormones,7.50E-04,290.44,0,3.93,3.93,15.14,0.45,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,91,(Alturki et al. 2013),5,,128,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,7.50E-04,296.4,0,3.98,4.11,10.24,0.31,6,HTI CTA FO,Flat-sheet membrane (active layer facing FS),64,-2.74,NaCl,58.44,0.5,25,9,5.36,4,22.5,96,(Alturki et al. 2013),5,,129,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,5.00E-07,290.32,1,0.26,0.59,7.04,0.41,7, PA FO ,unmodified polyamide (PA) membrane,68.3,-19.5,MgCl2,95.21,2,10,1.3,18,0.9,,81,(Dong et al. 2022),6,,130,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,5.00E-07,236.27,0,1.89,2.45,13.94,0.37,7, PA FO ,unmodified polyamide (PA) membrane,68.3,-19.5,MgCl2,95.21,2,10,1.3,18,0.9,,74.6,(Dong et al. 2022),6,Pharmaceutical Retention Mechanisms by ofiltration Membranes | Environmental Science & Technology (acs.org),131,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-07,253.28,-1,-0.22,0.79,1.39,0.38,7, PA FO ,unmodified polyamide (PA) membrane,68.3,-19.5,MgCl2,95.21,2,10,1.3,18,0.9,,83,(Dong et al. 2022),6,Pharmaceutical Retention Mechanisms by ofiltration Membranes | Environmental Science & Technology (acs.org),132,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,5.00E-07,290.32,1,0.26,0.59,7.04,0.41,7,CA-Na FO ,sodium citrate (CA-Na) modified membrane where Fe3+ was used here as a bridge to graft carboxylates to the PA surface.,43.8,-29.3,MgCl2,95.21,2,10,1.3,27.5,1.1,,92.1,(Dong et al. 2022),6,,133,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,5.00E-07,236.27,0,1.89,2.45,13.94,0.37,7,CA-Na FO ,sodium citrate (CA-Na) modified membrane where Fe3+ was used here as a bridge to graft carboxylates to the PA surface.,43.8,-29.3,MgCl2,95.21,2,10,1.3,27.5,1.1,,93.7,(Dong et al. 2022),6,Pharmaceutical Retention Mechanisms by ofiltration Membranes | Environmental Science & Technology (acs.org),134,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-07,253.28,-1,-0.22,0.79,1.39,0.38,7,CA-Na FO ,sodium citrate (CA-Na) modified membrane where Fe3+ was used here as a bridge to graft carboxylates to the PA surface.,43.8,-29.3,MgCl2,95.21,2,10,1.3,27.5,1.1,,96.7,(Dong et al. 2022),6,Pharmaceutical Retention Mechanisms by ofiltration Membranes | Environmental Science & Technology (acs.org),135,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,1,10,8.5,7.71,0.08,20,99.5,(Kim et al. 2017),7,,136,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,1,10,8.5,7.71,0.08,20,96.6,(Kim et al. 2017),7,,137,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,1,10,8.5,7.71,0.08,20,95.3,(Kim et al. 2017),7,,138,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,1,10,8.5,7.64,0.32,20,99.3,(Kim et al. 2017),7,,139,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,1,10,8.5,7.64,0.32,20,96.4,(Kim et al. 2017),7,,140,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,1,10,8.5,7.64,0.32,20,95.9,(Kim et al. 2017),7,,141,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,1,10,8.5,11.64,0.48,20,99.5,(Kim et al. 2017),7,,142,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,1,10,8.5,11.64,0.48,20,95.1,(Kim et al. 2017),7,,143,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,1,10,8.5,11.64,0.48,20,94.1,(Kim et al. 2017),7,,144,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,2,10,8.5,9.46,0.07,20,99.7,(Kim et al. 2017),7,,145,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,2,10,8.5,9.46,0.07,20,94.9,(Kim et al. 2017),7,,146,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,2,10,8.5,9.46,0.07,20,95.5,(Kim et al. 2017),7,,147,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,2,10,8.5,9.19,0.5,20,99.6,(Kim et al. 2017),7,,148,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,2,10,8.5,9.19,0.5,20,97.1,(Kim et al. 2017),7,,149,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,2,10,8.5,9.19,0.5,20,96.1,(Kim et al. 2017),7,,150,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,2,10,8.5,17.12,0.92,20,99.7,(Kim et al. 2017),7,,151,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,2,10,8.5,17.12,0.92,20,93.3,(Kim et al. 2017),7,,152,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,2,10,8.5,17.12,0.92,20,93.5,(Kim et al. 2017),7,,153,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,1,10,8.5,14.28,0.12,20,97.7,(Kim et al. 2017),7,,154,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,1,10,8.5,14.28,0.12,20,92.2,(Kim et al. 2017),7,,155,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Monoammonium Phosphate,115,1,10,8.5,14.28,0.12,20,90.6,(Kim et al. 2017),7,,156,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,1,10,8.5,16.18,0.26,20,99.2,(Kim et al. 2017),7,,157,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,1,10,8.5,16.18,0.26,20,98,(Kim et al. 2017),7,,158,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,Diammonium Phosphate,132.1,1,10,8.5,16.18,0.26,20,97.5,(Kim et al. 2017),7,,159,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.00E-02,266.34,1,-2.67,0.16,9.6,0.39,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,1,10,8.5,18.08,0.85,20,99.1,(Kim et al. 2017),7,,160,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,1.00E-02,215.7,0,2.64,2.61,1.7,0.35,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,1,10,8.5,18.08,0.85,20,94.1,(Kim et al. 2017),7,,161,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,1.00E-02,194.2,0,-0.63,-0.07,10.4,0.33,8,HTI CTA FO,"fertilizer-drawn forward osmosis (FDFO), AL-FS (active layer facing FS)",64.5,,KCl,74.6,1,10,8.5,18.08,0.85,20,91.8,(Kim et al. 2017),7,,162,,,,,,,,,,,,,,,,,,
N-nitrosodimethylamine,Disinfection byproduct,1.00E-02,74,0,-0.5,-0.64,-3.63,0.24,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,30.6,(Xu et al. 2018),8,,163,,,,,,,,,,,,,,,,,,
N-nitrosomethylethylamine,Disinfection byproduct,1.00E-02,88,0,0.01,-0.15,-3.39,0.29,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,70.6,(Xu et al. 2018),8,,164,,,,,,,,,,,,,,,,,,
N-nitrosodiethylamine,Disinfection byproduct,1.00E-02,102,0,0.52,0.34,-3.14,0.33,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,85.8,(Xu et al. 2018),8,,165,,,,,,,,,,,,,,,,,,
N-Nitrosodipropylamine,Disinfection byproduct,1.00E-02,130,0,1.54,1.33,-3.18,0.36,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,94.3,(Xu et al. 2018),8,,166,,,,,,,,,,,,,,,,,,
N-nitrosodi-n-butylamine,Disinfection byproduct,1.00E-02,158,0,2.56,2.31,-3.14,0.41,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,99.7,(Xu et al. 2018),8,,167,,,,,,,,,,,,,,,,,,
N-nitrosopyrrolidine,Disinfection byproduct,1.00E-02,100,0,-0.09,0.23,-3.14,0.35,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,81.4,(Xu et al. 2018),8,,168,,,,,,,,,,,,,,,,,,
N-nitrosopiperidine,Disinfection byproduct,1.00E-02,114,0,0.44,0.72,-3.18,0.41,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,91.1,(Xu et al. 2018),8,,169,,,,,,,,,,,,,,,,,,
Chloroform,Disinfection byproduct,2.00E-02,119,0,1.94,1.97,15.7,0.33,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,34.2,(Xu et al. 2018),8,,170,,,,,,,,,,,,,,,,,,
Bromodichloromethane,Disinfection byproduct,2.00E-02,164,0,2.04,2,2.93,0.44,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,59.6,(Xu et al. 2018),8,,171,,,,,,,,,,,,,,,,,,
Dibromochloromethane,Disinfection byproduct,2.00E-02,208,0,2.21,2.16,1.7,0.46,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,78.9,(Xu et al. 2018),8,,172,,,,,,,,,,,,,,,,,,
Bromoform,Disinfection byproduct,2.00E-02,253,0,2.43,2.4,8.6,0.43,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,86.6,(Xu et al. 2018),8,,173,,,,,,,,,,,,,,,,,,
Dichloroacetonitrile,Disinfection byproduct,2.00E-02,110,0,0.94,0.29,0.5,0.47,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,48.3,(Xu et al. 2018),8,,174,,,,,,,,,,,,,,,,,,
Bromochloroacetonitrile,Disinfection byproduct,2.00E-02,154,0,1.22,0.38,,0.53,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,67,(Xu et al. 2018),8,,175,,,,,,,,,,,,,,,,,,
Dibromoacetonitrile,Disinfection byproduct,2.00E-02,199,0,1.57,0.47,1.48,0.61,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,76.3,(Xu et al. 2018),8,,176,,,,,,,,,,,,,,,,,,
"1,1-Dichloro-2-propanone",Disinfection byproduct,2.00E-02,127,0,-0.28,0.2,10.4,,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,90.9,(Xu et al. 2018),8,,177,,,,,,,,,,,,,,,,,,
"1,1,1-Trichloro-2-propanone",Disinfection byproduct,2.00E-02,161,0,0.17,1.12,10,,7,Aquaporin FO,thin-film composite membrane with aquaporin protein embedded in the polyamide layer.,26.4,-55,NaCl,58.44,1,8,4.8,8.1,,21,95.4,(Xu et al. 2018),8,,178,,,,,,,,,,,,,,,,,,
N-nitrosodimethylamine,Disinfection byproduct,1.00E-02,74,0,-0.5,-0.64,-3.63,0.44,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,4.3,(Xu et al. 2018),8,,179,,,,,,,,,,,,,,,,,,
N-nitrosomethylethylamine,Disinfection byproduct,1.00E-02,88,0,0.01,-0.15,-3.39,0.49,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,21.3,(Xu et al. 2018),8,,180,,,,,,,,,,,,,,,,,,
N-nitrosodiethylamine,Disinfection byproduct,1.00E-02,102,0,0.52,0.34,-3.14,0.53,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,30.1,(Xu et al. 2018),8,,181,,,,,,,,,,,,,,,,,,
N-Nitrosodipropylamine,Disinfection byproduct,1.00E-02,130,0,1.54,1.33,-3.18,0.58,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,49.5,(Xu et al. 2018),8,,182,,,,,,,,,,,,,,,,,,
N-nitrosodi-n-butylamine,Disinfection byproduct,1.00E-02,158,0,2.56,2.31,-3.14,0.62,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,57.2,(Xu et al. 2018),8,,183,,,,,,,,,,,,,,,,,,
N-nitrosopyrrolidine,Disinfection byproduct,1.00E-02,100,0,-0.09,0.23,-3.14,0.5,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,21.3,(Xu et al. 2018),8,,184,,,,,,,,,,,,,,,,,,
N-nitrosopiperidine,Disinfection byproduct,1.00E-02,114,0,0.44,0.72,-3.18,0.53,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,39.7,(Xu et al. 2018),8,,185,,,,,,,,,,,,,,,,,,
Chloroform,Disinfection byproduct,2.00E-02,119,0,1.94,1.97,15.7,0.41,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,4,(Xu et al. 2018),8,,186,,,,,,,,,,,,,,,,,,
Bromodichloromethane,Disinfection byproduct,2.00E-02,164,0,2.04,2,2.93,0.47,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,16.2,(Xu et al. 2018),8,,187,,,,,,,,,,,,,,,,,,
Dibromochloromethane,Disinfection byproduct,2.00E-02,208,0,2.21,2.16,1.7,0.5,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,27.3,(Xu et al. 2018),8,,188,,,,,,,,,,,,,,,,,,
Bromoform,Disinfection byproduct,2.00E-02,253,0,2.43,2.4,8.6,0.48,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,36.8,(Xu et al. 2018),8,,189,,,,,,,,,,,,,,,,,,
Dichloroacetonitrile,Disinfection byproduct,2.00E-02,110,0,0.94,0.29,0.5,0.41,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,3.8,(Xu et al. 2018),8,,190,,,,,,,,,,,,,,,,,,
Bromochloroacetonitrile,Disinfection byproduct,2.00E-02,154,0,1.22,0.38,,0.42,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,19.8,(Xu et al. 2018),8,,191,,,,,,,,,,,,,,,,,,
Dibromoacetonitrile,Disinfection byproduct,2.00E-02,199,0,1.57,0.47,1.48,0.43,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,35.6,(Xu et al. 2018),8,,192,,,,,,,,,,,,,,,,,,
"1,1-Dichloro-2-propanone",Disinfection byproduct,2.00E-02,127,0,-0.28,0.2,9.1,,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,26.6,(Xu et al. 2018),8,,193,,,,,,,,,,,,,,,,,,
"1,1,1-Trichloro-2-propanone",Disinfection byproduct,2.00E-02,161,0,0.17,1.12,9.7,,7,HTI CTA FO,asymmetric cellulose triacetate membrane,58.3,-8,NaCl,58.44,1,8,4.8,6,,21,64.9,(Xu et al. 2018),8,,194,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.09E-02,266.34,1,-2.67,-2.09,9.43,0.46,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,98.7,(Li et al. 2021),9,,195,,,,,,,,,,,,,,,,,,
Sotalol,b-Blockers,1.29E-02,272.36,1,-3.03,-2.01,8.28,0.6,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.5,(Li et al. 2021),9,,196,,,,,,,,,,,,,,,,,,
Diatrizoic acid,X-ray contrast media,4.89E-02,613.92,-1,-0.46,-2.66,0.92,0.92,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.8,(Li et al. 2021),9,,197,,,,,,,,,,,,,,,,,,
Iohexol,X-ray contrast media,4.80E-02,821.14,0,-1.95,-2.92,11.35,0.91,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,98,(Li et al. 2021),9,,198,,,,,,,,,,,,,,,,,,
Iopamidol,X-ray contrast media,5.84E-02,777.08,0,-0.74,-2.54,10.87,1.01,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,98,(Li et al. 2021),9,,199,,,,,,,,,,,,,,,,,,
Iopromide,X-ray contrast media,2.90E-02,791.12,0,-0.44,-2.66,10.62,1.01,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,95,(Li et al. 2021),9,,200,,,,,,,,,,,,,,,,,,
Clarithromycin,Pharmaceutical,9.29E-03,747.95,1,0.35,1.71,8.16,0.96,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99,(Li et al. 2021),9,,201,,,,,,,,,,,,,,,,,,
Erythromycin,Pharmaceutical,6.02E-03,733.93,1,-0.28,0.81,13.09,1.3,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,91,(Li et al. 2021),9,,202,,,,,,,,,,,,,,,,,,
Sulfadiazine,Pharmaceutical,9.21E-03,250.28,-1,0.34,-0.68,6.81,0.63,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.9,(Li et al. 2021),9,,203,,,,,,,,,,,,,,,,,,
Sulfamethizole,Pharmaceutical,1.80E-02,270.33,-1,0.14,-0.68,2.07,0.69,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.9,(Li et al. 2021),9,,204,,,,,,,,,,,,,,,,,,
Metoprolol,b-Blockers,9.54E-03,267.36,1,-1.34,-0.81,9.43,0.56,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,98.9,(Li et al. 2021),9,,205,,,,,,,,,,,,,,,,,,
Tramadol,Analgesics,1.07E-02,263.38,1,-0.59,-0.06,9.61,0.63,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99,(Li et al. 2021),9,,206,,,,,,,,,,,,,,,,,,
Citalopram,Antidepressant,6.67E-03,324.29,1,0.44,1.02,9.57,0.87,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99,(Li et al. 2021),9,,207,,,,,,,,,,,,,,,,,,
Phenazone,Nonsteroidal anti-inflammatory,9.80E-03,188.23,0,1.21,0.44,0.65,0.47,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99,(Li et al. 2021),9,,208,,,,,,,,,,,,,,,,,,
Venlafaxine,Antidepressant,5.14E-03,277.4,1,-0.07,0.39,9.26,0.88,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99,(Li et al. 2021),9,,209,,,,,,,,,,,,,,,,,,
Propranolol,b-Blockers,1.01E-02,259.34,1,-0.51,0.45,9.5,0.61,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,98.2,(Li et al. 2021),9,,210,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,1.22E-02,253.28,-1,0.59,0.89,1.39,0.73,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.8,(Li et al. 2021),9,,211,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,1.07E-02,290.32,1,0.26,0.59,7.04,0.57,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.7,(Li et al. 2021),9,,212,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.37E-02,236.27,0,2.76,1.89,13.94,0.45,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99,(Li et al. 2021),9,,213,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,1.22E-02,206.29,-1,0.94,2.66,4.41,0.43,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,99.9,(Li et al. 2021),9,,214,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,9.66E-03,296.15,-1,2.26,1.77,4.18,0.51,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,24,17.5,12,2.5,24,100,(Li et al. 2021),9,,215,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,1.09E-02,266.34,1,-2.67,-2.09,9.43,0.34,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.9,(Li et al. 2021),9,,216,,,,,,,,,,,,,,,,,,
Sotalol,b-Blockers,1.29E-02,272.36,1,-3.03,-2.01,8.28,0.36,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.2,(Li et al. 2021),9,,217,,,,,,,,,,,,,,,,,,
Diatrizoic acid,X-ray contrast media,4.89E-02,613.92,-1,-0.46,-2.66,0.92,1.29,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.8,(Li et al. 2021),9,,218,,,,,,,,,,,,,,,,,,
Iohexol,X-ray contrast media,4.80E-02,821.14,0,-1.95,-2.92,11.35,0.71,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.7,(Li et al. 2021),9,,219,,,,,,,,,,,,,,,,,,
Iopamidol,X-ray contrast media,5.84E-02,777.08,0,-0.74,-2.54,10.87,0.65,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.3,(Li et al. 2021),9,,220,,,,,,,,,,,,,,,,,,
Iopromide,X-ray contrast media,2.90E-02,791.12,0,-0.44,-2.66,10.62,0.69,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,98.7,(Li et al. 2021),9,,221,,,,,,,,,,,,,,,,,,
Clarithromycin,Pharmaceutical,9.29E-03,747.95,1,0.35,1.71,8.16,0.56,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.4,(Li et al. 2021),9,,222,,,,,,,,,,,,,,,,,,
Erythromycin,Pharmaceutical,6.02E-03,733.93,1,-0.28,0.81,8.16,0.78,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,92.2,(Li et al. 2021),9,,223,,,,,,,,,,,,,,,,,,
Sulfadiazine,Pharmaceutical,9.21E-03,250.28,-1,0.34,-0.68,6.81,0.45,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.4,(Li et al. 2021),9,,224,,,,,,,,,,,,,,,,,,
Sulfamethizole,Pharmaceutical,1.80E-02,270.33,-1,0.14,-0.68,2.07,0.46,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.8,(Li et al. 2021),9,,225,,,,,,,,,,,,,,,,,,
Metoprolol,b-Blockers,9.54E-03,267.36,1,-1.34,-0.81,9.43,0.44,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.7,(Li et al. 2021),9,,226,,,,,,,,,,,,,,,,,,
Tramadol,Analgesics,1.07E-02,263.38,1,-0.59,-0.06,9.61,0.54,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,94.6,(Li et al. 2021),9,,227,,,,,,,,,,,,,,,,,,
Citalopram,Antidepressant,6.67E-03,324.29,1,0.44,1.02,9.57,0.53,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.4,(Li et al. 2021),9,,228,,,,,,,,,,,,,,,,,,
Phenazone,Nonsteroidal anti-inflammatory,9.80E-03,188.23,0,1.21,0.44,0.65,0.42,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.2,(Li et al. 2021),9,,229,,,,,,,,,,,,,,,,,,
Venlafaxine,Antidepressant,5.14E-03,277.4,1,-0.07,0.39,9.26,0.56,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.1,(Li et al. 2021),9,,230,,,,,,,,,,,,,,,,,,
Propranolol,b-Blockers,1.01E-02,259.34,1,-0.51,0.45,9.5,0.44,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.5,(Li et al. 2021),9,,231,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,1.22E-02,253.28,-1,0.59,0.89,1.39,0.45,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.5,(Li et al. 2021),9,,232,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,1.07E-02,290.32,1,0.26,0.59,7.04,0.44,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.3,(Li et al. 2021),9,,233,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.37E-02,236.27,0,2.76,1.89,13.94,0.48,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.7,(Li et al. 2021),9,,234,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,1.22E-02,206.29,-1,0.94,2.66,4.41,0.43,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.6,(Li et al. 2021),9,,235,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,9.66E-03,296.15,-1,2.26,1.77,4.18,0.49,7,Aquaporin FO,AQP FO hollow fiber membrane modules (Aquaporin HFFO2) were provided by Aquaporin A/S - thin film composite membrane with aquaporin proteins embedded in a polyamide active layer supported by a porous polysulfone support layer,26.4,,NaCl,58.44,0.7,2.5,17.5,10,2,20,99.1,(Li et al. 2021),9,,236,,,,,,,,,,,,,,,,,,
Clofibric acid,Lipid lowering drug,2.00E-03,214.6,-1,-1.29,2.43,3.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,83.43,(Xie et al. 2018),13,,255,,,,,,,,,,,,,,,,,,
Salicylic Acid,Personal care product,2.00E-03,138.1,-1,-1.14,2.26,3.01,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,98.75,(Xie et al. 2018),13,,256,,,,,,,,,,,,,,,,,,y
Ketoprofen,Analgesics,2.00E-03,254.3,-1,-0.55,2.91,4.23,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,98.3,(Xie et al. 2018),13,,257,,,,,,,,,,,,,,,,,,
Fenoprop,Pharmaceutical,2.00E-03,269.5,-1,-0.28,3.45,2.93,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,94.27,(Xie et al. 2018),13,,258,,,,,,,,,,,,,,,,,,
Naproxen,Analgesics,2.00E-03,230.3,-1,-0.18,2.88,4.84,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,98.21,(Xie et al. 2018),13,,259,,,,,,,,,,,,,,,,,,
Metronidazole,Pharmaceutical,2.00E-03,171.2,0,-0.14,-0.14,14.44,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,71.79,(Xie et al. 2018),13,,260,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.00E-03,206.3,-1,0.14,3.5,4.41,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,98.21,(Xie et al. 2018),13,,261,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,2.00E-03,218.3,0,0.83,0.91,12.26,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,97.22,(Xie et al. 2018),13,,262,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.00E-03,296.2,0,1.06,4.51,4.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.82,(Xie et al. 2018),13,,263,,,,,,,,,,,,,,,,,,
Gemfibrozil,Pharmaceutical,2.00E-03,250.3,-1,1.18,4.3,4.75,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.37,(Xie et al. 2018),13,,264,,,,,,,,,,,,,,,,,,
Propoxur,Pesticide,2.00E-03,209.2,-1,1.54,1.52,12.28,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,94.27,(Xie et al. 2018),13,,265,,,,,,,,,,,,,,,,,,
Enterolactone,,2.00E-03,298.33,0,1.88,1.89,9.93,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,98.12,(Xie et al. 2018),13,,266,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.00E-03,236.3,0,1.89,2.45,13.94,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,89.16,(Xie et al. 2018),13,,267,,,,,,,,,,,,,,,,,,
Pentachlorophenol,Organic Compounds,2.00E-03,266.4,0,2.19,5.12,4.68,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.01,(Xie et al. 2018),13,,268,,,,,,,,,,,,,,,,,,
DEET,Pesticide,2.00E-03,191.3,0,2.42,2.42,-1.37,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.64,(Xie et al. 2018),13,,269,,,,,,,,,,,,,,,,,,
Estriol,Hormones,2.00E-03,288.4,0,2.53,2.53,10.25,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,97.94,(Xie et al. 2018),13,,270,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,2.00E-03,215.7,0,2.64,2.2,2.27,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,95.61,(Xie et al. 2018),13,,271,,,,,,,,,,,,,,,,,,
Ametryn,Pesticide,2.00E-03,227.3,0,2.97,2.98,3.71,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,98.93,(Xie et al. 2018),13,,272,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,2.00E-03,277.4,1,3.21,4.92,9.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,94.09,(Xie et al. 2018),13,,273,,,,,,,,,,,,,,,,,,
Benzophenone,Endocrine disrupting chemicals,2.00E-03,182.2,0,3.21,3.18,,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,96.87,(Xie et al. 2018),13,,274,,,,,,,,,,,,,,,,,,
4-tert-Butylphenol,Organic Compounds,2.00E-03,150.2,0,3.39,3.4,10.13,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,83.79,(Xie et al. 2018),13,,275,,,,,,,,,,,,,,,,,,
Oxybenzone,Personal care product,2.00E-03,228.2,0,3.42,3.79,7.56,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.64,(Xie et al. 2018),13,,276,,,,,,,,,,,,,,,,,,
Estrone,Natural estrogens,2.00E-03,270.4,0,3.62,3.62,10.25,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.01,(Xie et al. 2018),13,,277,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,2.00E-03,228.3,0,3.64,3.32,10.29,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,96.69,(Xie et al. 2018),13,,278,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,2.00E-03,296.4,0,4.11,4.11,10.29,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,97.76,(Xie et al. 2018),13,,279,,,,,,,,,,,,,,,,,,
17beta-estradiol,Hormones,2.00E-03,272.4,0,4.14,4.14,10.27,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,97.94,(Xie et al. 2018),13,,280,,,,,,,,,,,,,,,,,,
Triclosan,Detergent,2.00E-03,289.5,0,4.93,5.17,7.9,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,97.67,(Xie et al. 2018),13,,281,,,,,,,,,,,,,,,,,,
Estradiol 17beta-acetate,Personal care product,2.00E-03,314.4,0,5.11,5.11,10.26,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,93.01,(Xie et al. 2018),13,,282,,,,,,,,,,,,,,,,,,
4-tert-Octylphenol,Organic Compounds,2.00E-03,206.3,0,5.18,3.4,10.13,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,99.73,(Xie et al. 2018),13,,283,,,,,,,,,,,,,,,,,,
Octocrylene,Personal care product,2.00E-03,361.5,0,6.89,6.89,,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,1,,9,,,25,96.51,(Xie et al. 2018),13,,284,,,,,,,,,,,,,,,,,,
Clofibric acid,Lipid lowering drug,2.00E-03,214.6,-1,-1.29,2.43,3.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.28,(Xie et al. 2018),13,,285,,,,,,,,,,,,,,,,,,
Salicylic Acid,Personal care product,2.00E-03,138.1,-1,-1.14,2.26,3.01,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.01,(Xie et al. 2018),13,,286,,,,,,,,,,,,,,,,,,
Ketoprofen,Analgesics,2.00E-03,254.3,-1,-0.55,2.91,4.23,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.37,(Xie et al. 2018),13,,287,,,,,,,,,,,,,,,,,,
Fenoprop,Pharmaceutical,2.00E-03,269.5,-1,-0.28,3.45,2.93,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.55,(Xie et al. 2018),13,,288,,,,,,,,,,,,,,,,,,
Naproxen,Analgesics,2.00E-03,230.3,-1,-0.18,2.88,4.84,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,100,(Xie et al. 2018),13,,289,,,,,,,,,,,,,,,,,,
Metronidazole,Pharmaceutical,2.00E-03,171.2,0,-0.14,-0.14,14.44,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,90.24,(Xie et al. 2018),13,,290,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.00E-03,206.3,-1,0.14,3.5,4.41,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.46,(Xie et al. 2018),13,,291,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,2.00E-03,218.3,0,0.83,0.91,12.26,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.46,(Xie et al. 2018),13,,292,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.00E-03,296.2,0,1.06,4.51,4.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.64,(Xie et al. 2018),13,,293,,,,,,,,,,,,,,,,,,
Gemfibrozil,Pharmaceutical,2.00E-03,250.3,-1,1.18,4.3,4.75,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.19,(Xie et al. 2018),13,,294,,,,,,,,,,,,,,,,,,
Propoxur,Pesticide,2.00E-03,209.2,-1,1.54,1.52,12.28,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.64,(Xie et al. 2018),13,,295,,,,,,,,,,,,,,,,,,
Enterolactone,,2.00E-03,298.33,0,1.88,1.89,9.93,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.64,(Xie et al. 2018),13,,296,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.00E-03,236.3,0,1.89,2.45,13.94,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,98.66,(Xie et al. 2018),13,,297,,,,,,,,,,,,,,,,,,
Pentachlorophenol,Organic Compounds,2.00E-03,266.4,0,2.19,5.12,4.68,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.1,(Xie et al. 2018),13,,298,,,,,,,,,,,,,,,,,,
DEET,Pesticide,2.00E-03,191.3,0,2.42,2.42,-1.37,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.73,(Xie et al. 2018),13,,299,,,,,,,,,,,,,,,,,,
Estriol,Hormones,2.00E-03,288.4,0,2.53,2.53,10.25,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,98.3,(Xie et al. 2018),13,,300,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,2.00E-03,215.7,0,2.64,2.2,2.27,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,98.66,(Xie et al. 2018),13,,301,,,,,,,,,,,,,,,,,,
Ametryn,Pesticide,2.00E-03,227.3,0,2.97,2.98,3.71,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.37,(Xie et al. 2018),13,,302,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,2.00E-03,277.4,1,3.21,4.92,9.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,100,(Xie et al. 2018),13,,303,,,,,,,,,,,,,,,,,,
Benzophenone,Endocrine disrupting chemicals,2.00E-03,182.2,0,3.21,3.18,,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,98.93,(Xie et al. 2018),13,,304,,,,,,,,,,,,,,,,,,
4-tert-Butylphenol,Organic Compounds,2.00E-03,150.2,0,3.39,3.4,10.13,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,90.42,(Xie et al. 2018),13,,305,,,,,,,,,,,,,,,,,,
Oxybenzone,Personal care product,2.00E-03,228.2,0,3.42,3.79,7.56,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.91,(Xie et al. 2018),13,,306,,,,,,,,,,,,,,,,,,
Estrone,Natural estrogens,2.00E-03,270.4,0,3.62,3.62,10.25,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.82,(Xie et al. 2018),13,,307,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,2.00E-03,228.3,0,3.64,3.32,10.29,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,97.76,(Xie et al. 2018),13,,308,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,2.00E-03,296.4,0,4.11,4.11,10.29,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,98.84,(Xie et al. 2018),13,,309,,,,,,,,,,,,,,,,,,
17beta-estradiol,Hormones,2.00E-03,272.4,0,4.14,4.14,10.27,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.46,(Xie et al. 2018),13,,310,,,,,,,,,,,,,,,,,,
Triclosan,Detergent,2.00E-03,289.5,0,4.93,5.17,7.9,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.46,(Xie et al. 2018),13,,311,,,,,,,,,,,,,,,,,,
Estradiol 17beta-acetate,Personal care product,2.00E-03,314.4,0,5.11,5.11,10.26,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,99.01,(Xie et al. 2018),13,,312,,,,,,,,,,,,,,,,,,
4-tert-Octylphenol,Organic Compounds,2.00E-03,206.3,0,5.18,3.4,10.13,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,100,(Xie et al. 2018),13,,313,,,,,,,,,,,,,,,,,,
Octocrylene,Personal care product,2.00E-03,361.5,0,6.89,6.89,,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,2,,9,,,25,96.87,(Xie et al. 2018),13,,314,,,,,,,,,,,,,,,,,,
Clofibric acid,Lipid lowering drug,2.00E-03,214.6,-1,-1.29,2.43,3.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,80.48,(Xie et al. 2018),13,,315,,,,,,,,,,,,,,,,,,
Salicylic Acid,Personal care product,2.00E-03,138.1,-1,-1.14,2.26,3.01,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,97.67,(Xie et al. 2018),13,,316,,,,,,,,,,,,,,,,,,
Ketoprofen,Analgesics,2.00E-03,254.3,-1,-0.55,2.91,4.23,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,97.58,(Xie et al. 2018),13,,317,,,,,,,,,,,,,,,,,,
Fenoprop,Pharmaceutical,2.00E-03,269.5,-1,-0.28,3.45,2.93,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,89.7,(Xie et al. 2018),13,,318,,,,,,,,,,,,,,,,,,
Naproxen,Analgesics,2.00E-03,230.3,-1,-0.18,2.88,4.84,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,96.69,(Xie et al. 2018),13,,319,,,,,,,,,,,,,,,,,,
Metronidazole,Pharmaceutical,2.00E-03,171.2,0,-0.14,-0.14,14.44,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,67.76,(Xie et al. 2018),13,,320,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.00E-03,206.3,-1,0.14,3.5,4.41,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,81.1,(Xie et al. 2018),13,,321,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,2.00E-03,218.3,0,0.83,0.91,12.26,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,94.45,(Xie et al. 2018),13,,322,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.00E-03,296.2,0,1.06,4.51,4.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,96.33,(Xie et al. 2018),13,,323,,,,,,,,,,,,,,,,,,
Gemfibrozil,Pharmaceutical,2.00E-03,250.3,-1,1.18,4.3,4.75,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,98.75,(Xie et al. 2018),13,,324,,,,,,,,,,,,,,,,,,
Propoxur,Pesticide,2.00E-03,209.2,-1,1.54,1.52,12.28,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,88.45,(Xie et al. 2018),13,,325,,,,,,,,,,,,,,,,,,
Enterolactone,,2.00E-03,298.33,0,1.88,1.89,9.93,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,96.51,(Xie et al. 2018),13,,326,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.00E-03,236.3,0,1.89,2.45,13.94,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,86.75,(Xie et al. 2018),13,,327,,,,,,,,,,,,,,,,,,
Pentachlorophenol,Organic Compounds,2.00E-03,266.4,0,2.19,5.12,4.68,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,88.81,(Xie et al. 2018),13,,328,,,,,,,,,,,,,,,,,,
DEET,Pesticide,2.00E-03,191.3,0,2.42,2.42,-1.37,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,99.55,(Xie et al. 2018),13,,329,,,,,,,,,,,,,,,,,,
Estriol,Hormones,2.00E-03,288.4,0,2.53,2.53,10.25,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,97.49,(Xie et al. 2018),13,,330,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,2.00E-03,215.7,0,2.64,2.2,2.27,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,92.93,(Xie et al. 2018),13,,331,,,,,,,,,,,,,,,,,,
Ametryn,Pesticide,2.00E-03,227.3,0,2.97,2.98,3.71,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,96.96,(Xie et al. 2018),13,,332,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,2.00E-03,277.4,1,3.21,4.92,9.18,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,90.06,(Xie et al. 2018),13,,333,,,,,,,,,,,,,,,,,,
Benzophenone,Endocrine disrupting chemicals,2.00E-03,182.2,0,3.21,3.18,,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,87.64,(Xie et al. 2018),13,,334,,,,,,,,,,,,,,,,,,
4-tert-Butylphenol,Organic Compounds,2.00E-03,150.2,0,3.39,3.4,10.13,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,72.69,(Xie et al. 2018),13,,335,,,,,,,,,,,,,,,,,,
Oxybenzone,Personal care product,2.00E-03,228.2,0,3.42,3.79,7.56,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,96.06,(Xie et al. 2018),13,,336,,,,,,,,,,,,,,,,,,
Estrone,Natural estrogens,2.00E-03,270.4,0,3.62,3.62,10.25,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,96.15,(Xie et al. 2018),13,,337,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,2.00E-03,228.3,0,3.64,3.32,10.29,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,95.97,(Xie et al. 2018),13,,338,,,,,,,,,,,,,,,,,,
17-alpha-Ethinyl estradiol,Hormones,2.00E-03,296.4,0,4.11,4.11,10.29,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,93.28,(Xie et al. 2018),13,,339,,,,,,,,,,,,,,,,,,
17beta-estradiol,Hormones,2.00E-03,272.4,0,4.14,4.14,10.27,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,90.24,(Xie et al. 2018),13,,340,,,,,,,,,,,,,,,,,,
Triclosan,Detergent,2.00E-03,289.5,0,4.93,5.17,7.9,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,95.07,(Xie et al. 2018),13,,341,,,,,,,,,,,,,,,,,,
Estradiol 17beta-acetate,Personal care product,2.00E-03,314.4,0,5.11,5.11,10.26,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,89.7,(Xie et al. 2018),13,,342,,,,,,,,,,,,,,,,,,
4-tert-Octylphenol,Organic Compounds,2.00E-03,206.3,0,5.18,3.4,10.13,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,99.28,(Xie et al. 2018),13,,343,,,,,,,,,,,,,,,,,,
Octocrylene,Personal care product,2.00E-03,361.5,0,6.89,6.89,,,6.5,Aquaporin FO,,68.1,-17,NaCl,58.44,0.5,,9,15,,25,85.85,(Xie et al. 2018),13,,344,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,3,TiO2 FO,TiO2 modified FO membrane,27.04,-5.4,NaCl,58.44,0.5,16,25,,,25,91.6,(Huang et al. 2015),14,,345,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,3,TiO2 FO,TiO2 modified FO membrane,27.04,-5.4,NaCl,58.44,0.5,16,25,,,25,89.6,(Huang et al. 2015),14,,346,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,3,TiO2 FO,TiO2 modified FO membrane,27.04,-5.4,NaCl,58.44,0.5,16,25,,,25,95.6,(Huang et al. 2015),14,,347,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,3,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-3.3,NaCl,58.44,0.5,16,25,,,25,82.48,(Huang et al. 2015),14,,348,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,3,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-3.3,NaCl,58.44,0.5,16,25,,,25,84.8,(Huang et al. 2015),14,,349,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,3,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-3.3,NaCl,58.44,0.5,16,25,,,25,90.6,(Huang et al. 2015),14,,350,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,5,TiO2 FO,TiO2 modified FO membrane,27.04,-29.1,NaCl,58.44,0.5,16,25,,,25,88.5,(Huang et al. 2015),14,,351,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,5,TiO2 FO,TiO2 modified FO membrane,27.04,-29.1,NaCl,58.44,0.5,16,25,,,25,94.5,(Huang et al. 2015),14,,352,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,5,TiO2 FO,TiO2 modified FO membrane,27.04,-29.1,NaCl,58.44,0.5,16,25,,,25,96.9,(Huang et al. 2015),14,,353,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,5,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-23.4,NaCl,58.44,0.5,16,25,,,25,80.33,(Huang et al. 2015),14,,354,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,5,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-23.4,NaCl,58.44,0.5,16,25,,,25,91.7,(Huang et al. 2015),14,,355,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,5,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-23.4,NaCl,58.44,0.5,16,25,,,25,94.05,(Huang et al. 2015),14,,356,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,7,TiO2 FO,TiO2 modified FO membrane,27.04,-42.48,NaCl,58.44,0.5,16,25,,,25,90.2,(Huang et al. 2015),14,,357,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,7,TiO2 FO,TiO2 modified FO membrane,27.04,-42.48,NaCl,58.44,0.5,16,25,,,25,99.1,(Huang et al. 2015),14,,358,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,7,TiO2 FO,TiO2 modified FO membrane,27.04,-42.48,NaCl,58.44,0.5,16,25,,,25,98.2,(Huang et al. 2015),14,,359,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,7,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-33.35,NaCl,58.44,0.5,16,25,,,25,81.65,(Huang et al. 2015),14,,360,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,7,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-33.35,NaCl,58.44,0.5,16,25,,,25,94.7,(Huang et al. 2015),14,,361,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,7,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-33.35,NaCl,58.44,0.5,16,25,,,25,96.86,(Huang et al. 2015),14,,362,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,9,TiO2 FO,TiO2 modified FO membrane,27.04,-45.65,NaCl,58.44,0.5,16,25,,,25,89.8,(Huang et al. 2015),14,,363,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,9,TiO2 FO,TiO2 modified FO membrane,27.04,-45.65,NaCl,58.44,0.5,16,25,,,25,99.5,(Huang et al. 2015),14,,364,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,9,TiO2 FO,TiO2 modified FO membrane,27.04,-45.65,NaCl,58.44,0.5,16,25,,,25,99.6,(Huang et al. 2015),14,,365,,,,,,,,,,,,,,,,,,
Metoprolol,Pharmaceutical,5.00E-01,267.4,1,-1.34,1.88,9.49,,9,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-36.84,NaCl,58.44,0.5,16,25,,,25,80,(Huang et al. 2015),14,,366,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,5.00E-01,253.3,-1,-0.22,0.89,1.39,,9,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-36.84,NaCl,58.44,0.5,16,25,,,25,96.7,(Huang et al. 2015),14,,367,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,5.00E-01,289.6,0,4.93,5.17,7.9,,9,TFC Polysulfocate FO,Thin film composite polysulfonate forward osmosis (FO),37.17,-36.84,NaCl,58.44,0.5,16,25,,,25,98.51,(Huang et al. 2015),14,,368,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,2.00E-03,277,1,2.28,4.92,9.18,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,85.88,(Xie et al. 2014),15,,369,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,2.00E-03,290,1,0.27,0.91,7.04,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,94.27,(Xie et al. 2014),15,,370,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,2.00E-03,253,-1,-0.96,0.89,5.18,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,98.47,(Xie et al. 2014),15,,371,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.00E-03,296,-1,1.77,4.55,4.18,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,99.24,(Xie et al. 2014),15,,372,,,,,,,,,,,,,,,,,,
Bezafibrate,Pharmaceutical,2.00E-03,362,-1,-0.93,2.5,3.29,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,91.98,(Xie et al. 2014),15,,373,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,2.00E-03,194,0,-0.63,-0.07,0.52,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,63.74,(Xie et al. 2014),15,,374,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,2.00E-03,216,0,2.64,2.2,2.27,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,85.11,(Xie et al. 2014),15,,375,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,2.00E-03,218,0,0.83,0.91,12.26,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,70.23,(Xie et al. 2014),15,,376,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.00E-03,236,0,1.89,2.45,13.94,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,91.6,(Xie et al. 2014),15,,377,,,,,,,,,,,,,,,,,,
Pentachlorophenol,Organic Compounds,2.00E-03,266,0,2.85,5.12,4.68,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,81.3,(Xie et al. 2014),15,,378,,,,,,,,,,,,,,,,,,
Linuron,Pesticide,2.00E-03,249,0,3.12,3.12,12.13,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,88.17,(Xie et al. 2014),15,,379,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,2.00E-03,290,0,5.28,4.76,7.8,,7,HTI PA FO,,,-17.8,NaCl,58.44,1,20,9,14.13,,25,98.55,(Xie et al. 2014),15,,380,,y,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,2.00E-03,277,1,2.28,4.92,9.18,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,75.62,(Xie et al. 2014),15,,381,,,,,,,,,,,,,,,,,,
Trimethoprim,Pharmaceutical,2.00E-03,290,1,0.27,0.91,7.04,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,77.9,(Xie et al. 2014),15,,382,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,2.00E-03,253,-1,-0.96,0.89,5.18,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,83.62,(Xie et al. 2014),15,,383,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.00E-03,296,-1,1.77,4.55,4.18,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,94.67,(Xie et al. 2014),15,,384,,,,,,,,,,,,,,,,,,
Bezafibrate,Pharmaceutical,2.00E-03,362,-1,-0.93,2.5,3.29,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,95.05,(Xie et al. 2014),15,,385,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,2.00E-03,194,0,-0.63,-0.07,0.52,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,43.62,(Xie et al. 2014),15,,386,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,2.00E-03,216,0,2.64,2.2,2.27,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,71.05,(Xie et al. 2014),15,,387,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,2.00E-03,218,0,0.83,0.91,12.26,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,61.9,(Xie et al. 2014),15,,388,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.00E-03,236,0,1.89,2.45,13.94,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,85.14,(Xie et al. 2014),15,,389,,,,,,,,,,,,,,,,,,
Pentachlorophenol,Organic Compounds,2.00E-03,266,0,2.85,5.12,4.68,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,71.43,(Xie et al. 2014),15,,390,,,,,,,,,,,,,,,,,,
Linuron,Pesticide,2.00E-03,249,0,3.12,3.12,12.13,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,72.19,(Xie et al. 2014),15,,391,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,2.00E-03,290,0,5.28,4.76,7.8,,7,HTI PA FO,,,-17.8,NaCl,58.44,0.25,20,9,7.75,,25,92,(Xie et al. 2014),15,,392,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,6,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,13.1,,24,95.67,"(Jin et al., 2012)",16,,393,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,2.58,4.51,4.08,,6,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,13.1,,24,94.39,"(Jin et al., 2012)",16,,394,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,2.43,3.97,4.47,,6,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,13.1,,24,82.04,"(Jin et al., 2012)",16,,395,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,1.37,3.18,4.2,,6,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,13.1,,24,73.25,"(Jin et al., 2012)",16,,396,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,6,HTI CTA-W,flat membrane coupon with a woven support,73,-4,NaCl,58.44,2,2,23.2,11.84,,24,94.78,"(Jin et al., 2012)",16,,397,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,2.58,4.51,4.08,,6,HTI CTA-W,flat membrane coupon with a woven support,73,-4,NaCl,58.44,2,2,23.2,11.84,,24,92.36,"(Jin et al., 2012)",16,,398,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,2.43,3.97,4.47,,6,HTI CTA-W,flat membrane coupon with a woven support,73,-4,NaCl,58.44,2,2,23.2,11.84,,24,83.18,"(Jin et al., 2012)",16,,399,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,1.37,3.18,4.2,,6,HTI CTA-W,flat membrane coupon with a woven support,73,-4,NaCl,58.44,2,2,23.2,11.84,,24,63.82,"(Jin et al., 2012)",16,,400,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,6,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.3,,24,95.92,"(Jin et al., 2012)",16,,401,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,2.58,4.51,4.08,,6,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.3,,24,95.67,"(Jin et al., 2012)",16,,402,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,2.43,3.97,4.47,,6,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.3,,24,95.54,"(Jin et al., 2012)",16,,403,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,1.37,3.18,4.2,,6,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.3,,24,94.01,"(Jin et al., 2012)",16,,404,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,6,TFC PA-2,Polyamide active layer,45,-6,NaCl,58.44,2,2,23.2,29.34,,24,96.94,"(Jin et al., 2012)",16,,405,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,2.58,4.51,4.08,,6,TFC PA-2,Polyamide active layer,45,-6,NaCl,58.44,2,2,23.2,29.34,,24,96.56,"(Jin et al., 2012)",16,,406,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,2.43,3.97,4.47,,6,TFC PA-2,Polyamide active layer,45,-6,NaCl,58.44,2,2,23.2,29.34,,24,96.56,"(Jin et al., 2012)",16,,407,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,1.37,3.18,4.2,,6,TFC PA-2,Polyamide active layer,45,-6,NaCl,58.44,2,2,23.2,29.34,,24,94.9,"(Jin et al., 2012)",16,,408,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,3,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,97.68,"(Jin et al., 2012)",16,,409,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,4.48,4.51,4.08,,3,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,99.64,"(Jin et al., 2012)",16,,410,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,3.96,3.97,4.47,,3,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,96.61,"(Jin et al., 2012)",16,,411,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,3.15,3.18,3.18,,3,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,96.07,"(Jin et al., 2012)",16,,412,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,8,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,96.61,"(Jin et al., 2012)",16,,413,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,0.59,4.51,4.08,,8,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,99.73,"(Jin et al., 2012)",16,,414,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,0.44,3.97,4.47,,8,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,95,"(Jin et al., 2012)",16,,415,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,-0.62,3.18,4.2,,8,TFC PA-1,Polyamide active layer,43,-6,NaCl,58.44,2,2,23.2,16.34,,24,98.04,"(Jin et al., 2012)",16,,416,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,3,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,97.23,"(Jin et al., 2012)",16,,417,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,4.48,4.51,4.08,,3,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,97.47,"(Jin et al., 2012)",16,,418,y,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,3.96,3.97,4.47,,3,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,92.05,"(Jin et al., 2012)",16,,419,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,3.15,3.18,4.2,,3,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,89.04,"(Jin et al., 2012)",16,,420,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,2.50E-01,236,0,2.45,2.45,13.94,,8,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,94.7,"(Jin et al., 2012)",16,,421,,,,,,,,,,,,,,,,,,
Diclofenac,Pharmaceutical,2.50E-01,296,-1,0.59,4.51,4.08,,8,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,98.92,"(Jin et al., 2012)",16,,422,,,,,,,,,,,,,,,,,,
Ibuprofen,Pharmaceutical,2.50E-01,206.3,-1,0.44,3.97,4.47,,8,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,93.25,"(Jin et al., 2012)",16,,423,,,,,,,,,,,,,,,,,,
Naproxen,Pharmaceutical,2.50E-01,230,-1,-0.62,3.18,4.2,,8,HTI CTA-HW,membrane coupon cut from a Hydrowell® FO module,63,-2,NaCl,58.44,2,2,23.2,11.84,,24,93.13,"(Jin et al., 2012)",16,,424,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,5.00E+00,228.29,0,3.64,3.32,10.29,,7,HTI CTA-TA,CTA membrane with active layer (AL) coated with TA-FeCL3 complex coating,44.55,-40,NaCl,58.44,1,2,28,12.8,2.7,,50.4,,17,,425,,,,,,,,,,,,,,,,,,
4-hydroxybenzoic acid,Organic Compounds,5.00E+00,138.12,-1,-1.06,1.58,4.54,,7,HTI CTA-TA,CTA membrane with active layer (AL) coated with TA-FeCL3 complex coating,44.55,-40,NaCl,58.44,1,2,28,12.8,2.7,,,,17,,426,,,,,,,,,,,,,,,,,,
Cinnamic acid,,5.00E+00,148.16,0,2.14,2.14,4.44,,7,HTI CTA-TA,CTA membrane with active layer (AL) coated with TA-FeCL3 complex coating,44.55,-40,NaCl,58.44,1,2,28,12.8,2.7,,,,17,,427,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,5.00E+00,228.29,0,3.64,3.32,10.29,,7,HTI CTA FO,cellulose triacetate membrane,57.75,-45,NaCl,58.44,1,2,28,10.63,3.03,,84,,17,,428,,,,,,,,,,,,,,,,,,
4-hydroxybenzoic acid,Organic Compounds,5.00E+00,138.12,-1,-1.06,1.58,4.54,,7,HTI CTA FO,cellulose triacetate membrane,57.75,-45,NaCl,58.44,1,2,28,10.63,3.03,,50.9,,17,,429,,,,,,,,,,,,,,,,,,
Cinnamic acid,,5.00E+00,148.16,0,2.14,2.14,4.44,,7,HTI CTA FO,cellulose triacetate membrane,57.75,-45,NaCl,58.44,1,2,28,10.63,3.03,,46,,17,,430,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,1.00E-02,289.5,0,5.28,4.8,7.9,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,93.4,(Lee et al. 2019),18,,431,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,1.00E-02,289.5,0,5.28,4.8,7.9,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,98.7,(Lee et al. 2019),18,,432,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.00E-02,236.3,0,2.45,2.5,13.9,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,73,(Lee et al. 2019),18,,433,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.00E-02,236.3,0,2.45,2.5,13.9,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,96,(Lee et al. 2019),18,,434,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,1.00E-02,228.3,0,3.64,3.3,9.6,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,85.5,(Lee et al. 2019),18,,435,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,1.00E-02,228.3,0,3.64,3.3,9.6,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,95.7,(Lee et al. 2019),18,,436,,,,,,,,,,,,,,,,,,
Triclocarban,Herbicide,1.00E-02,315.6,0,6.07,4.3,12.7,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,92.5,(Lee et al. 2019),18,,437,,,,,,,,,,,,,,,,,,
Triclocarban,Herbicide,1.00E-02,315.6,0,6.07,4.3,12.7,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,98.5,(Lee et al. 2019),18,,438,,,,,,,,,,,,,,,,,,
"2,4-dichlorophenol",Organic Compounds,1.00E-02,163,1,3.06,3.1,7.9,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,68.8,(Lee et al. 2019),18,,439,,,,,,,,,,,,,,,,,,
"2,4-dichlorophenol",Organic Compounds,1.00E-02,163,1,3.06,3.1,7.9,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,81.5,(Lee et al. 2019),18,,440,,,,,,,,,,,,,,,,,,
Acridine,Organic Compounds,1.00E-02,179.2,1,3.43,3.4,5.5,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,82,(Lee et al. 2019),18,,441,,,,,,,,,,,,,,,,,,
Acridine,Organic Compounds,1.00E-02,179.2,1,3.43,3.4,5.5,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,90,(Lee et al. 2019),18,,442,,,,,,,,,,,,,,,,,,
4-isopropylphenol,Organic Compounds,1.00E-02,136.2,1,2.99,2.9,10.2,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,53.6,(Lee et al. 2019),18,,443,,,,,,,,,,,,,,,,,,
4-isopropylphenol,Organic Compounds,1.00E-02,136.2,1,2.99,2.9,10.2,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,88.9,(Lee et al. 2019),18,,444,,,,,,,,,,,,,,,,,,
4-chloroaniline,Organic Compounds,1.00E-02,127.6,-1,1.95,1.8,4,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.48,16.07,,68.9,(Lee et al. 2019),18,,445,,,,,,,,,,,,,,,,,,
4-chloroaniline,Organic Compounds,1.00E-02,127.6,-1,1.95,1.8,4,,5,HTI PA FO,Thin film composite Polyamide based forward osmosis (FO),40.3,-13.8,NaCl,58.44,0.5,4,,19.89,6.32,,85,(Lee et al. 2019),18,,446,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,1.00E-02,289.5,0,5.28,4.8,7.9,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,97.1,(Lee et al. 2019),18,,447,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.00E-02,236.3,0,2.45,2.5,13.9,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,76,(Lee et al. 2019),18,,448,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,1.00E-02,228.3,0,3.64,3.3,9.6,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,90.2,(Lee et al. 2019),18,,449,,,,,,,,,,,,,,,,,,
Triclocarban,Herbicide,1.00E-02,315.6,0,6.07,4.3,12.7,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,96.3,(Lee et al. 2019),18,,450,,,,,,,,,,,,,,,,,,
"2,4-dichlorophenol",Organic Compounds,1.00E-02,163,1,3.06,3.1,7.9,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,70.2,(Lee et al. 2019),18,,451,,,,,,,,,,,,,,,,,,
Acridine,Organic Compounds,1.00E-02,179.2,-1,3.43,3.4,5.5,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,85,(Lee et al. 2019),18,,452,,,,,,,,,,,,,,,,,,
4-isopropylphenol,Organic Compounds,1.00E-02,136.2,1,2.99,2.9,10.2,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,16.11,,56.9,(Lee et al. 2019),18,,453,,,,,,,,,,,,,,,,,,
4-chloroaniline,Organic Compounds,1.00E-02,127.6,-1,1.95,1.8,4,,7,HTI CTA FO,cellulose triacetate material,50,-1.09,NaCl,58.44,0.5,4,,7.32,15.47,,76.6,(Lee et al. 2019),18,,454,,,,,,,,,,,,,,,,,,
Triclosan,Pharmaceutical,1.00E-02,289.5,0,5.28,4.8,7.9,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,98.8,(Lee et al. 2019),18,,455,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,1.00E-02,236.3,0,2.45,2.5,13.9,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,83,(Lee et al. 2019),18,,456,,,,,,,,,,,,,,,,,,
Bisphenol A,Endocrine disrupting chemicals,1.00E-02,228.3,0,3.64,3.3,9.6,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,93.4,(Lee et al. 2019),18,,457,,,,,,,,,,,,,,,,,,
Triclocarban,Herbicide,1.00E-02,315.6,0,6.07,4.3,12.7,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,98.5,(Lee et al. 2019),18,,458,,,,,,,,,,,,,,,,,,
"2,4-dichlorophenol",Organic Compounds,1.00E-02,163,1,3.06,3.1,7.9,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,81.5,(Lee et al. 2019),18,,459,,,,,,,,,,,,,,,,,,
Acridine,Organic Compounds,1.00E-02,179.2,1,3.43,3.4,5.5,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,87,(Lee et al. 2019),18,,460,,,,,,,,,,,,,,,,,,
4-isopropylphenol,Organic Compounds,1.00E-02,136.2,1,2.99,2.9,10.2,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,88.9,(Lee et al. 2019),18,,461,,,,,,,,,,,,,,,,,,
4-chloroaniline,Organic Compounds,1.00E-02,127.6,-1,1.95,1.8,4,,5,HTI CTA FO,cellulose triacetate material,50,-1.09,MgSO4,120.366,2.5,4,,7.61,1.13,,85,(Lee et al. 2019),18,,462,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,11.11111111,3.54,,76.86567093,"(Cui et al., 2016)",19,,445,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,9.607844633,,,72.82157568,"(Cui et al., 2016)",19,,446,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,500,123.11,0,1.92,1.92,1.3,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,15.74074074,3.54,,77.61194203,"(Cui et al., 2016)",19,,447,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1500,123.11,0,1.92,1.92,1.3,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,13.58024738,3.54,,75.22388406,"(Cui et al., 2016)",19,,448,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,14.68750054,3.54,,73.76505829,"(Cui et al., 2016)",19,,449,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,10,,,66.34854812,"(Cui et al., 2016)",19,,450,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,500,94.11,0,1.54,1.46,9.86,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,17.93750039,3.54,,75.42168725,"(Cui et al., 2016)",19,,451,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,2000,94.11,0,1.54,1.46,9.86,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,15.18749996,3.54,,71.50602194,"(Cui et al., 2016)",19,,452,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,16.00000029,3.54,,91.83734911,"(Cui et al., 2016)",19,,453,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,10.98039066,,,88.00830053,"(Cui et al., 2016)",19,,454,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,500,93.13,0,1.13,0.9,4.61,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,18.06249989,3.54,,91.83734911,"(Cui et al., 2016)",19,,455,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,2000,93.13,0,1.13,0.9,4.61,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,14.68750054,3.54,,88.22289094,"(Cui et al., 2016)",19,,456,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,8.35365823,4.27,,75.71428571,"(Cui et al., 2016)",19,,457,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,5.588235294,,,67.5,"(Cui et al., 2016)",19,,458,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,500,123.11,0,1.92,1.92,1.3,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,9.939022518,4.27,,80.31746274,"(Cui et al., 2016)",19,,459,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1500,123.11,0,1.92,1.92,1.3,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,8.597559784,4.27,,74.12698655,"(Cui et al., 2016)",19,,460,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,11.4462818,4.27,,76.50407,"(Cui et al., 2016)",19,,461,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,8.823529412,,,64,"(Cui et al., 2016)",19,,462,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,500,94.11,0,1.54,1.46,9.86,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,11.69421572,4.27,,79.10569354,"(Cui et al., 2016)",19,,463,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,2000,94.11,0,1.54,1.46,9.86,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,8.636361573,4.27,,73.90243902,"(Cui et al., 2016)",19,,464,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,10.12396696,4.27,,88.37398622,"(Cui et al., 2016)",19,,465,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,7.352941176,,,86.38,"(Cui et al., 2016)",19,,466,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,500,93.13,0,1.13,0.9,4.61,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,12.27272693,4.27,,90.97560976,"(Cui et al., 2016)",19,,467,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,2000,93.13,0,1.13,0.9,4.61,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,10.37190087,4.27,,92.76423012,"(Cui et al., 2016)",19,,468,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,15.98684201,4.05,,75.32258327,"(Cui et al., 2016)",19,,469,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,9.512985478,,,66.72199213,"(Cui et al., 2016)",19,,470,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,500,123.11,0,1.92,1.92,1.3,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,16.57894721,4.05,,76.93548482,"(Cui et al., 2016)",19,,471,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1500,123.11,0,1.92,1.92,1.3,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,13.22368439,4.05,,72.25806071,"(Cui et al., 2016)",19,,472,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,18.10810798,4.05,,72.03124737,"(Cui et al., 2016)",19,,473,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,11.65584135,,,65.60166011,"(Cui et al., 2016)",19,,474,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,500,94.11,0,1.54,1.46,9.86,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,17.5,4.05,,76.87500156,"(Cui et al., 2016)",19,,475,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,2000,94.11,0,1.54,1.46,9.86,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,16.41891863,4.05,,71.71875218,"(Cui et al., 2016)",19,,476,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,16.82432395,4.05,,91.56249743,"(Cui et al., 2016)",19,,477,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,0.5,2,1.25,13.99350392,,,86.63900394,"(Cui et al., 2016)",19,,478,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,500,93.13,0,1.13,0.9,4.61,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,17.5,4.05,86.37500381,90.46874994,"(Cui et al., 2016)",19,,479,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,2000,93.13,0,1.13,0.9,4.61,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,1,2,1.25,16.28378403,4.05,67.5,91.87499978,"(Cui et al., 2016)",19,,480,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,16.57,,,92.5,"(Cui et al., 2016)",19,,481,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,12.75,,,84.5,"(Cui et al., 2016)",19,,482,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,Matrimid TFC PA,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,15.98,,,75.5,"(Cui et al., 2016)",19,,483,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,21.96078581,,,91.86722004,"(Cui et al., 2016)",19,,484,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,18.43137404,,,80.78837926,"(Cui et al., 2016)",19,,485,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,PESU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,20.09803772,,,79.5435678,"(Cui et al., 2016)",19,,486,,,,,,,,,,,,,,,,,,
Aniline,Aromatic compounds,1000,93.13,0,1.13,0.9,4.61,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,27.62987039,,,91.24481146,"(Cui et al., 2016)",19,,487,,,,,,,,,,,,,,,,,,
Nitrobenzene,Aromatic compounds,1000,123.11,0,1.92,1.92,1.3,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,21.1038972,,,80.53942039,"(Cui et al., 2016)",19,,488,,,,,,,,,,,,,,,,,,
Phenol,Aromatic compounds,1000,94.11,0,1.54,1.46,9.86,,,sPPSU TFC,Lab-fabricated TFC membranes,,,NaCl,58.44,2,2,1.25,23.73376759,,,81.65975241,"(Cui et al., 2016)",19,,489,,,,,,,,,,,,,,,,,,
Amitriptyline,Pharmaceutical,0.025,313.87,1,2.28,,,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,97.3,,20,,490,,,,,,,,,,,,,,,,,,
Atenolol,b-Blockers,0.025,266.34,1,-2.09,,,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,57.8,,20,,491,,,,,,,,,,,,,,,,,,
Atrazine,Pesticide,0.025,215.69,0,2.64,,,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,90.5,,20,,492,,,,,,,,,,,,,,,,,,
Caffeine,Stimulant,0.025,194.19,0,-0.63,,,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,91,,20,,493,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.025,236,0,1.89,,,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,96.2,,20,,494,,,,,,,,,,,,,,,,,,
Primidone,Pharmaceutical,0.025,218.25,0,0.83,,,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,95.5,,20,,495,,,,,,,,,,,,,,,,,,
Sulfamethoxazole,Pharmaceutical,0.025,253.28,-1,-0.22,0.89,1.39,,7,Toray TFC PA,Thin-film composite (TFC) polyamide (PA) FO membrane from Toray,,,NaCl,58.44,0.6,24,8.5,19.25,,25,94,,20,,496,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,0.33,12,15.54,5.77,22,94.27,"(Fini et al., 2020)",21,,497,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,hollow fiber membranes,58.6,-41,NaCl,58.44,1,0.33,,15.55,1.65,22,98.72,"(Fini et al., 2020)",21,,497,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,0.66,12,15.54,5.77,22,94.05,"(Fini et al., 2020)",21,,498,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1,12,15.54,5.77,22,93.98,"(Fini et al., 2020)",21,,499,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1.33,12,15.54,5.77,22,93.9,"(Fini et al., 2020)",21,,500,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1.66,12,15.54,5.77,22,94.27,"(Fini et al., 2020)",21,,501,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2,12,15.54,5.77,22,94.2,"(Fini et al., 2020)",21,,502,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2.33,12,15.54,5.77,22,93.68,"(Fini et al., 2020)",21,,503,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2.66,12,15.54,5.77,22,93.9,"(Fini et al., 2020)",21,,504,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3,12,15.54,5.77,22,93.61,"(Fini et al., 2020)",21,,505,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3.33,12,15.54,5.77,22,94.12,"(Fini et al., 2020)",21,,506,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3.66,12,15.54,5.77,22,93.76,"(Fini et al., 2020)",21,,507,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4,12,15.54,5.77,22,93.46,"(Fini et al., 2020)",21,,508,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4.33,12,15.54,5.77,22,93.54,"(Fini et al., 2020)",21,,509,,,,,,,,,,,,,,,,,,
"2,6-Dichlorobenzamide",Pesticide,1,190.028,0,0.8,0.77,14.73,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4.66,12,15.54,5.77,22,93.54,"(Fini et al., 2020)",21,,510,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,0.33,12,15.54,5.77,22,98.03738262,"(Fini et al., 2020)",21,,511,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,hollow fiber membranes,58.6,-41,NaCl,58.44,1,0.33,,15.55,1.65,22,99.2,"(Fini et al., 2020)",21,,511,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,0.66,12,15.54,5.77,22,97.38,"(Fini et al., 2020)",21,,512,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1,12,15.54,5.77,22,97.1,"(Fini et al., 2020)",21,,513,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1.33,12,15.54,5.77,22,97.01,"(Fini et al., 2020)",21,,514,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1.66,12,15.54,5.77,22,96.82,"(Fini et al., 2020)",21,,515,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2,12,15.54,5.77,22,96.78,"(Fini et al., 2020)",21,,516,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2.33,12,15.54,5.77,22,96.45,"(Fini et al., 2020)",21,,517,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2.66,12,15.54,5.77,22,96.45,"(Fini et al., 2020)",21,,518,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3,12,15.54,5.77,22,96.07,"(Fini et al., 2020)",21,,519,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3.33,12,15.54,5.77,22,96.3,"(Fini et al., 2020)",21,,520,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3.66,12,15.54,5.77,22,96.07,"(Fini et al., 2020)",21,,521,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4,12,15.54,5.77,22,95.89,"(Fini et al., 2020)",21,,522,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4.33,12,15.54,5.77,22,95.79,"(Fini et al., 2020)",21,,523,,,,,,,,,,,,,,,,,,
2-methyl-4-chlorophenoxyaceticacid,Pesticide,1,200.62,-1,2.6,2.73,3.07,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4.66,12,15.54,5.77,22,95.65,"(Fini et al., 2020)",21,,524,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,0.33,12,15.54,5.77,22,97.05,"(Fini et al., 2020)",21,,525,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,0.66,12,15.54,5.77,22,96.9,"(Fini et al., 2020)",21,,526,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1,12,15.54,5.77,22,96.9,"(Fini et al., 2020)",21,,527,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1.33,12,15.54,5.77,22,96.57,"(Fini et al., 2020)",21,,528,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,1.66,12,15.54,5.77,22,96.42,"(Fini et al., 2020)",21,,529,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2,12,15.54,5.77,22,96.38,"(Fini et al., 2020)",21,,530,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2.33,12,15.54,5.77,22,96.42,"(Fini et al., 2020)",21,,531,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,2.66,12,15.54,5.77,22,96.42,"(Fini et al., 2020)",21,,532,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3,12,15.54,5.77,22,96,"(Fini et al., 2020)",21,,533,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3.33,12,15.54,5.77,22,96.33,"(Fini et al., 2020)",21,,534,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,3.66,12,15.54,5.77,22,96.1,"(Fini et al., 2020)",21,,535,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4,12,15.54,5.77,22,95.81,"(Fini et al., 2020)",21,,536,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4.33,12,15.54,5.77,22,95.86,"(Fini et al., 2020)",21,,537,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,hollow fiber membranes,58.6,-41,NaCl,58.44,1,0.33,,15.55,1.65,22,99.15,"(Fini et al., 2020)",21,,537,,,,,,,,,,,,,,,,,,
2-(4-Chloro-2-methylphenoxy)propionic acid,Pesticide,1,214.65,-1,-0.92,2.56,2.56,,5.3,Aquaporin FO,flat sheet membranes,58.6,-41,NaCl,58.44,1,4.66,12,15.54,5.77,22,95.62,"(Fini et al., 2020)",21,,538,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,10,9,5.9,2.4,23,91.85,"(Xie et al., 2012)",22,,567,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,10,9,5.9,2.4,23,54.4,"(Xie et al., 2012)",22,,568,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,10,9,6.63,2.3,23,69.84732358,"(Xie et al., 2012)",22,,569,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,10,9,6.63,2.3,23,56.3,"(Xie et al., 2012)",22,,570,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,10,9,6.57,2.64,23,64.31297793,"(Xie et al., 2012)",22,,571,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,10,9,6.57,2.64,23,65.3,"(Xie et al., 2012)",22,,572,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,10,9,6.66,2.57,23,59.16030588,"(Xie et al., 2012)",22,,573,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,10,9,6.66,2.57,23,93.7,"(Xie et al., 2012)",22,,574,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,10,9,7.54,2.78,23,57.251903,"(Xie et al., 2012)",22,,575,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,10,9,7.54,2.78,23,98.7,"(Xie et al., 2012)",22,,576,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,9,9,,,23,54.38930741,"(Xie et al., 2012)",22,,577,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,9,9,,,23,51.3,"(Xie et al., 2012)",22,,578,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,9,9,,,23,85,"(Xie et al., 2012)",22,,579,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,9,9,,,23,59.4,"(Xie et al., 2012)",22,,580,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,9,9,,,23,98.26,"(Xie et al., 2012)",22,,581,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,9,9,,,23,62.8,"(Xie et al., 2012)",22,,582,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,9,9,,,23,95,"(Xie et al., 2012)",22,,583,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,9,9,,,23,93.5,"(Xie et al., 2012)",22,,584,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,9,9,,,23,91.7,"(Xie et al., 2012)",22,,585,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,9,9,,,23,97.9,"(Xie et al., 2012)",22,,586,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,8,9,,,23,92.6,"(Xie et al., 2012)",22,,587,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,8,9,,,23,57.3,"(Xie et al., 2012)",22,,588,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,8,9,,,23,97.8,"(Xie et al., 2012)",22,,589,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,8,9,,,23,59.5,"(Xie et al., 2012)",22,,590,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,8,9,,,23,94.13,"(Xie et al., 2012)",22,,591,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,8,9,,,23,61,"(Xie et al., 2012)",22,,592,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,8,9,,,23,90,"(Xie et al., 2012)",22,,593,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,8,9,,,23,93.9,"(Xie et al., 2012)",22,,594,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,8,9,,,23,96.3,"(Xie et al., 2012)",22,,595,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,8,9,,,23,98.3,"(Xie et al., 2012)",22,,596,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,7,9,,,23,89.13,"(Xie et al., 2012)",22,,597,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,7,9,,,23,59,"(Xie et al., 2012)",22,,598,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,7,9,,,23,97.17,"(Xie et al., 2012)",22,,599,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,7,9,,,23,60,"(Xie et al., 2012)",22,,600,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,7,9,,,23,98.69,"(Xie et al., 2012)",22,,601,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,7,9,,,23,68.9,"(Xie et al., 2012)",22,,602,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,7,9,,,23,,"(Xie et al., 2012)",22,,603,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,7,9,,,23,93.7,"(Xie et al., 2012)",22,,604,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,7,9,,,23,95.43,"(Xie et al., 2012)",22,,605,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,7,9,,,23,98.9,"(Xie et al., 2012)",22,,606,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,6,9,,,23,91.08,"(Xie et al., 2012)",22,,607,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,5,9,,,23,96.3,"(Xie et al., 2012)",22,,608,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,5,9,,,23,65.8,"(Xie et al., 2012)",22,,609,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,6,9,,,23,59.2,"(Xie et al., 2012)",22,,610,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,6,9,,,23,96.95,"(Xie et al., 2012)",22,,611,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,5,9,,,23,90.87,"(Xie et al., 2012)",22,,612,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,5,9,,,23,59.5,"(Xie et al., 2012)",22,,613,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,6,9,,,23,58,"(Xie et al., 2012)",22,,614,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,6,9,,,23,98.26,"(Xie et al., 2012)",22,,615,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,5,9,,,23,88.04,"(Xie et al., 2012)",22,,616,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,5,9,,,23,67.4,"(Xie et al., 2012)",22,,617,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,6,9,,,23,66,"(Xie et al., 2012)",22,,618,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,6,9,,,23,98.39,"(Xie et al., 2012)",22,,619,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,5,9,,,23,87.17,"(Xie et al., 2012)",22,,620,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,5,9,,,23,94.3,"(Xie et al., 2012)",22,,621,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,6,9,,,23,93.3,"(Xie et al., 2012)",22,,622,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,6,9,,,23,99.13,"(Xie et al., 2012)",22,,623,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,5,9,,,23,93.9,"(Xie et al., 2012)",22,,624,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,5,9,,,23,98.9,"(Xie et al., 2012)",22,,625,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,6,9,,,23,98.9,"(Xie et al., 2012)",22,,626,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,4,9,,,23,93.04,"(Xie et al., 2012)",22,,627,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,4,9,,,23,64.31,"(Xie et al., 2012)",22,,628,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,4,9,,,23,92.39,"(Xie et al., 2012)",22,,629,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,4,9,,,23,65.5,"(Xie et al., 2012)",22,,630,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,4,9,,,23,93.04,"(Xie et al., 2012)",22,,631,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,4,9,,,23,64.5,"(Xie et al., 2012)",22,,632,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,4,9,,,23,94.56,"(Xie et al., 2012)",22,,633,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,4,9,,,23,91,"(Xie et al., 2012)",22,,634,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,4,9,,,23,97.17,"(Xie et al., 2012)",22,,635,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,4,9,,,23,98.5,"(Xie et al., 2012)",22,,636,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,3,9,,,23,92.61,"(Xie et al., 2012)",22,,637,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,3,9,,,23,69.5,"(Xie et al., 2012)",22,,638,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,3,9,,,23,90.56,"(Xie et al., 2012)",22,,639,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,3,9,,,23,61.6,"(Xie et al., 2012)",22,,640,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,3,9,,,23,96,"(Xie et al., 2012)",22,,641,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,3,9,,,23,64.5,"(Xie et al., 2012)",22,,642,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,3,9,,,23,95.43,"(Xie et al., 2012)",22,,643,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,3,9,,,23,92.6,"(Xie et al., 2012)",22,,644,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,3,9,,,23,97.17,"(Xie et al., 2012)",22,,645,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,3,9,,,23,99,"(Xie et al., 2012)",22,,646,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,2,9,,,23,94.34,"(Xie et al., 2012)",22,,647,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,2,9,,,23,69.8,"(Xie et al., 2012)",22,,648,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,2,9,,,23,91.74,"(Xie et al., 2012)",22,,649,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,2,9,,,23,63.7,"(Xie et al., 2012)",22,,650,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,2,9,,,23,94.5,"(Xie et al., 2012)",22,,651,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,2,9,,,23,65,"(Xie et al., 2012)",22,,652,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,2,9,,,23,96.5,"(Xie et al., 2012)",22,,653,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,2,9,,,23,97.9,"(Xie et al., 2012)",22,,654,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,2,9,,,23,94.5,"(Xie et al., 2012)",22,,655,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,2,9,,,23,100,"(Xie et al., 2012)",22,,656,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,1,9,,,23,97.39,"(Xie et al., 2012)",22,,657,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,3.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,70.9,-0.8,NaCl,58.44,1,1,9,,,23,85.1,"(Xie et al., 2012)",22,,658,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,1,9,,,23,92.82,"(Xie et al., 2012)",22,,659,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,4.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,66.7,-1.49,NaCl,58.44,1,1,9,,,23,84,"(Xie et al., 2012)",22,,660,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,1,9,,,23,87.61,"(Xie et al., 2012)",22,,661,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,5.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,64.8,-2.29,NaCl,58.44,1,1,9,,,23,81.7,"(Xie et al., 2012)",22,,662,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,1,9,,,23,90.65,"(Xie et al., 2012)",22,,663,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,6.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,62.8,-2.97,NaCl,58.44,1,1,9,,,23,93.3,"(Xie et al., 2012)",22,,664,,,,,,,,,,,,,,,,,,
Carbamazepine,Pharmaceutical,0.25,236.3,0,1.89,2.45,9.73,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,1,9,,,23,95.65,"(Xie et al., 2012)",22,,665,,,,,,,,,,,,,,,,,,
Sulfamethoxazole ,Pharmaceutical,0.25,253.3,-1,-0.22,0.89,1.39,,7.5,HTI CTA FO, the active layer of the FO membrane was placed against the feed solution,60.2,-3.14,NaCl,58.44,1,1,9,,,23,98.3,"(Xie et al., 2012)",22,,666,,,,,,,,,,,,,,,,,,
